Reference(s)
Click here to return to the Reference Table

Category: Carcinomas
Cancer type: Thyroid
Descriptor: HGF/SF expression


Reference Number: 127
Papotti, M. et al. Expression of hepatocyte growth factor O(HGF) and its receptor (MET) in medullary carcinoma of the thyroid. Endocrine Pathology 11, 19-30 (2000).
PubMed link      E-mail link

Reference Number: 250
Trovato M, Grosso M, Vitarelli E, Ruggeri RM, Alesci S, Trimarchi F, Barresi G, Benvenga S. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas. Histol Histopathol 18:393-9 (2003).
PubMed link      E-mail link

Reference Number: 329
Scarpino S, Di Napoli A, Taraboletti G, Cancrini A, Ruco LP. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells. J Pathol. 205, 50-6 (2005)
PubMed link      E-mail link

Reference Number: 559
Ghoneim C, Soula-Rothhut M, Blanchevoye C, Martiny L, Antonicelli F, Rothhut B. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion. J Biol Chem. 282, 15490-7 (2007)
PubMed link      E-mail link

Reference Number: 1178
Ruggeri RM, Vitarelli E, Barresi G, Trimarchi F, Benvenga S, Trovato M. HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization. Histol Histopathol. 27, 113-21 (2012)
PubMed link      E-mail link

Reference Number: 1616
Koo BS, Kim JM, Seo ST, Yoon YH, Kwon KR, Kim SH, Kwon HW, Bae WJ, Lim YC. Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol. 21, 2310-7 (2014)
PubMed link      E-mail link